Objective The significance of estimated glomerular filtration rate (e-GFR) 
Introduction

Diabetic nephropathy is the leading cause of end-stage renal disease (ESRD), and the number of individuals requiring chronic dialysis or renal transplantation is still increasing in most countries (1). Clinical staging of diabetic nephropathy is based mainly on urinary albumin excretion rate (AER) and, in the advanced stage, reduced glomerular filtration rate (GFR), as well, as follows: stage 1, no evidence of microalbuminuria; stage 2, microalbuminuria; stage 3, macroalbuminuria; stage 4, reduced GFR; and stage 5, dialysis or renal transplantation. It is assumed that the progression of diabetic nephropathy to ESRD is more common in the advanced clinical stage. Yokoyama et al and Ueda et al inde-equation modified for Japanese subjects in June 2007 (9). However, since the earlier stages of diabetic nephropathy are not diagnosed based on GFR, discrepancy between e-GFR and AER has often left physicians with the question of whether e-GFR adds further risk of deterioration of renal function in subjects with diabetic nephropathy without albuminuria.
In this study, we prospectively examined a hospital-based study cohort to evaluate the significance of both the clinical staging of diabetic nephropathy based on the level of AER and staging based on e-GFR for a three-year progression of renal dysfunction.
Methods
All of the subjects admitted to our hospital for a 2- 
Results
The baseline characteristics of this study cohort and the dropout subjects are shown in (12) . In their study, e-GFR tended to decrease in the albuminuric subjects, though not to a statistically significant extent. As discussed in their article, this was probably because of the small sample size of their study.
T a b l e 1 . B a s e l i n e Ch a r a c t e r i s t i c s o f t h e S t u d y Co h o r t a n d t h e Dr o p o u t S u b j e c t s irrespective of e-GFR
T a b l e 2 . Di f f e r e n c e s i n B a s e l i n e Va l u e s b e t we e n t h e T wo Gr o u p s Di v i d e d a cc o r d i n g t o e -GF R L e v e l a f t e r 3 Ye a r s
Di a b e t i c n e p h r o p a t h y i s s u b d i v i d e d i n t o n o n e / mi c r o a l b u mi n u r i a / ma c r o a l b u mi n u r i a a n d d i a b e t i c r e t i n o p a t h y i n t o n o n e / b a c k g r o u n d / mo r e a d v a n c e d s t a g e o r p r i o r p h o t o c o a g u l a t i o n . Nu mb e r s o f s u b j e c t s i n e a c h s t a g e a r e l i s t e d i n t h i s t a b l e .
The second question concerns the etiology of renal insufficiency. In this study, we did not perform renal biopsy for determination of pathophysiological status. It is thus possible that other etiologies of renal disease such as nephrosclerosis coexisted with diabetic nephropathy. The existence or not of albuminuria was associated with striking differences in rate of disease progression irrespective of e-GFR level in this study. Although it is natural to suppose that this difference in the findings was associated with differences in underlying etiology, determining the etiology of renal dysfunction in type 2 diabetes mellitus is difficult. Renal biopsy is usually considered if the medical history or the results of urinalysis suggest an etiology other than diabetic nephropathy (10). Those subjects whose e-GFR declined to less than
As for the development of CVD, our study showed only
T a b l e 3 . Re s u l t s o f L o g i s t i c Re g r e s s i o n An a l y s i s o f As s o c i a t i o n s wi t h E s t i ma t e d GF R De c l i n e a f t e r 3 Ye a r s
Mo
Mo d e l C wa s a n a l y z e d o n l y wi t h t h e s e c l i n i c a l s t a g i n g s .
F i g u r e 1 . Nu mb e r s a n d p e r c e n t a g e s o f s u b j e c t s wh o s e e s t i ma t e d GF R d e c l i n e d t o l o
we r t h a n 3 0 mL / mi n / 1 . 7 3 m 2 a f t e r 3 y e a r s . B a r s r e p r e s e n t p e r c e n t a g e s , wh i l e e x a c t n u mb e r s a n d p e r c e n t a g e s a r e i n d i c a t e d n e a r t h e b a r f o r e a c h c a t e g o r T a b l e 4 . Nu mb e r s a n d P e r c e n t a g e s o f S u b j e c t s wh o De v e l o p e d Ca r d i o v a s c u  l 
a r Di s e a s e wi t h i n 3 Ye a r s
De n o mi n a t o r s r e p r e s e n t t h e n u mb e r s o f s u b j e c t s i n e a c h c a t e g o r y a n d n u me r a t o r s r e p r e s e n t t h e n u mb e r s o f s u b j e c t s wh o d e v e l o p e d c a r d i o v a s c u l a r d i s e a s e wi t h i n 3 y e a r s . T h e n u mb e r s i n p a r e n t h e s i s r e p r e s e n t t h e p e r c e n t a g e o f s u b j e c t s It has been widely reported that RAS blockade prevents further deterioration of diabetic nephropathy (15 
